info@trade-jp.net
menu
News / Blog
New Year Holidays 2024 / 2025
03/12/2024
Please pay attention that due to local holidays in Japan (End of Year holidays – Dec 27th to Jan 5th) we shall operate as follows:
ORDER
Catalog
Home
Disorders
Glaucoma and cataract
GLA-ALPHA combination ophthalmic solution for glaucoma and ocular hypertension (Glanatec, ripasudil, brimonidine)
| Product Code |
|
| Availability | 7 |
| Price | USD 395.00 |
| Qty |
GLA-ALPHA combination ophthalmic solution for glaucoma and ocular hypertension (Glanatec, ripasudil, brimonidine)
Product Code :
Availability : 7
USD 395.00
Is GLA-ALPHA combination ophthalmic solution effective for the treatment of glaucoma and ocular hypertension (Glanatec, ripasudil, brimonidine)?
For those seeking an effective glaucoma treatment, GLA-ALPHA combination ophthalmic solution is a promising option. This innovative solution brings together two powerful active ingredients: ripasudil hydrochloride hydrate and brimonidine tartrate. Known commercially as Glanatec ophthalmic solution, ripasudil works by inhibiting rho-kinase, which enhances the outflow of aqueous humor through the trabecular meshwork and Schlemm’s canal. Meanwhile, brimonidine tartrate, an Alpha-2 adrenergic receptor agonist, reduces intraocular pressure by both decreasing the production of aqueous humor and increasing its outflow via the uveoscleral pathway.
Combining these two components in GLA-ALPHA not only improves their individual efficacy but also provides a superior glaucoma treatment. Glanatec glaucoma solution specifically targets the primary channels responsible for fluid drainage in the eye, thereby reducing intraocular pressure effectively. The synergy between ripasudil and brimonidine tartrate offers a comprehensive approach to managing glaucoma and ocular hypertension, ensuring better patient outcomes.
Proven Effectiveness in Lowering Intraocular Pressure
Scientific research supports the effectiveness of GLA-ALPHA combination ophthalmic solution. For instance, studies on ripasudil hydrochloride hydrate, a key ingredient in Glanatec glaucoma eye drops, have demonstrated significant intraocular pressure reduction. According to the research article "Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection," ripasudil showed an average intraocular pressure reduction of 3.5 mmHg at trough levels and 4.5 mmHg at peak levels after eight weeks of treatment. This data underscores the potential of ripasudil as a safer and effective alternative to traditional prostaglandin analogues.
GLA-ALPHA combination ophthalmic solution not only excels in lowering intraocular pressure but also ensures a robust safety profile. Patients can rely on the dual-action mechanism of ripasudil and brimonidine tartrate to maintain optimal eye health. By targeting both the trabecular meshwork and uveoscleral pathways, this solution provides a holistic approach to managing glaucoma and ocular hypertension.
In summary, GLA-ALPHA combination ophthalmic solution, featuring the potent ingredients found in Glanatec glaucoma eye drops, offers a highly effective and scientifically validated treatment for glaucoma and ocular hypertension. By leveraging the combined benefits of ripasudil and brimonidine tartrate, patients can achieve significant reductions in intraocular pressure, leading to better management of their condition and improved quality of life. For those in search of a reliable and efficient glaucoma treatment, GLA-ALPHA is an excellent choice.
Package details: 5 bottles * 5 ml
Dosage and administration: use 1 drop at a time, 2 times a day
Active components: ripasudil hydrochloride hydrate, brimonidine tartrate
Therapeutic effect: treatment of glaucoma and ocular hypertension
Contraindications and precautions: Store in a dry cool place, out of reach of children. Do not use for pregnant or breastfeeding women. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.
There are no reviews for this product.
Write a review
Rating
Bad
Good
Related Products
News
New Year Holidays 2024 / 2025
03/12/2024
Please pay attention that due to local holidays in Japan (End of Year holidays – Dec 27th to Jan 5th) we shall operate as follows:
ORDER ACCEPTANCE
We stop accepting orders during holidays from Dec 26th to Jan 3rd. Website will not allow orders, please order on Jan 3rd, evening (Japanese time)
No suppliers will operate this week so changes in shipping time / price / product availability are possible. Product may become unavailable as well.
Please pay attention: orders paid after Dec 15th may be shipped after Jan 6th because Japan Post and courier services will not operate during Holidays. If you pay before we are 99% likely to ship before holidays. If you pay after make sure you can wait as delays are possible due to end of year holidays. Some suppliers stop working before Dec 26th, please pay attention!
SUPPORT TEAM and PAYMENT CONFIRMATIONS
Will not work on Dec 31st , Jan 1st Jan 2nd - No email of any urgency will be replied. Thank you for understanding. Do not send sseveral emails during this period.
We shall resume support work on Jan 3rd, but we may need time to reply.
We shall continue to work as usual starting Jan 6th.
Pay attention that payments may be affected by your local holidays in your country / country of payment systems (during Christmas holidays and New Year holidays).
SHIPIPNG - DELAYS till January 10th.
We stop shipping all orders from Dec 28th to Jan 6th. Japan Post and courtier services will not work during this period so there are possible delays for some orders (mainly injections and some tablets) paid after Dec 15th
We shall resume normal work from Monday 6th.